Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: A novel target for the treatment of working memory dysfunction

Psychopharmacology

Volumn 174, Issue 1, 2004, Pages 143-150

  Lewis, David A ^a   Volk, David W ^a   Hashimoto, Takanori ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Chandelier neuron; GABA receptor; Pyramidal neuron; Working memory

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; MESSENGER RNA; PROTEIN DERIVATIVE; PROTEIN SUBUNIT;

COGNITION; CORRELATION ANALYSIS; DRUG EFFECT; DRUG SCREENING; DRUG SELECTIVITY; DRUG TARGETING; GABAERGIC SYSTEM; HUMAN; MEMORY CONSOLIDATION; NERVE CELL; NERVE EXCITABILITY; NERVE FIBER; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REVIEW; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; UPREGULATION;

EID: 3142726152     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1673-x     Document Type: Review

References (91)

1. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney Jr WE, Jones EG (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52:258-266
2. Anderson SA, Classey JD, Condé F, Lund JS, Lewis DA (1995) Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience 67:7-22
3. Anderson SA, Eisenstat DD, Shi L, Rubenstein JLR (1997) Interneuron migration from basal forebrain to neocortex: dependence on D1x genes. Science 278:474-476
4. Andreasen NC, Rezai R, Alliger R, Swayze VW, II, Flaum M, Kirchner P, Cohen G, O'Leary DS (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 49:943-958
5. A receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50:291-313
6. Beasley CL, Zhang ZJ, Patten I, Reynolds GP (2002) Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol Psychiatry 52:708-715
7. Ben-Ari Y (2002) Excitatory actions of GABA during development: The nature of the nurture. Nat Rev Neurosci 3:728-739
8. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL (1991) Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48:996-1001
9. Benes FM, Snyder-Marie A, Vincent S, Khan Y (1996) Up-regulation of GABA-A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75:1021-1031
10. Blum BP, Mann JJ (2002) The GABAergic system in schizophrenia. Int J Neuropsychopharmacol 5:159-179
11. Botvinick MM, Braver TS, Barch DM, Carter CS, Cohen JD (2001) Conflict monitoring and cognitive control. Psychol Rev 108:624-652
12. Brunig I, Scotti E, Sidler C, Fritschy JM (2002) Intact sorting, targeting, and clustering of gamma-aminobutyric acid A receptor subtypes in hippocampal neurons in vitro. J Comp Neurol 443:43-55
13. Buchsbaum M (1990) The frontal lobes, basal ganglia and temporal lobes as sites for schizophrenia. Schizophr Bull 16:379-389
14. Callicott JH, Tallent K, Bertolino A, Ransey N, Santha A, Knable M, Coppola R, Goldberg T, Mattay V, van Gelderen P, Frank JA, Moonen CTW, Weinberger DR (1998) fMRI brain mapping in psychiatry. Neuropsychopharmacology 18:186-196
15. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA, Goldberg TE, Weinberger DR (1999) Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 9:20-26
16. Callicott JH, Bertolino A, Mattay VS, Langheim FJP, Duyn J, Coppola R, Goldberg TE, Weinberger DR (2000) Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 10:1078-1092
17. Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Breier AF (1999) Diazepam treatment of early signs of exacerbation in schizophrenia. Am J Psychiatry 156:299-303
18. Carter CS, Robertson L, Chaderjian M, Celaya L, Nardahl T (1992) Attentional asymmetry in schizophrenia: controlled and automatic processes. Biol Psychiatry 31:909-918
19. Carter CS, Robertson L, Nordhal TE, Kraft L, Chaderjian M, Oshora-Celaya L (1996) Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenic patients. Biol Psychiatry 40:930-932
20. Carter CS, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen JD (1998) Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 155:1285-1287
21. Carter CS, Botvinick M, Cohen JD (1999) The contribution of the anterior cingulate cortex to executive processes in cognition. Rev Neurosci 10:49-57
22. Cobb SR, Buhl EH, Halasy K, Paulsen O, Somogyi P (1995) Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378:75-78
23. Cohen JD, Botvinick M, Carter CS (2002) Anterior cingulate and prefrontal cortex: who's in control. Nat Neurosci 3:421-423
24. A receptor. J Neurosci 22:5572-5580
25. Condé F, Lund JS, Jacobowitz DM, Baimbridge KG, Lewis DA (1994) Local circuit neurons immunoreactive for calretinin, calbindin D-28 k, or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol 341:95-116
26. Cornblatt BA, Lenzenweger MF, Erlenmeyer-Kimling L (1989) The continuous performance test, identical pairs version: II. Contrasting attention profiles in schizophrenic and depressed patients. Psychiatry Res 29:65-85
27. A receptors. Proc Natl Acad Sci USA 99:8980-8985
28. Cruz DA, Eggan SM, Lewis DA (2003) Postnatal development of pre- and post-synaptic GABA markers at chandelier cell inputs to pyramidal neurons in monkey prefrontal cortex. J Comp Neurol 465:385-400
29. DeFelipe J (1997) Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat 14:1-19
30. DeFelipe J, del Carmen Gonzalez-Albo M (1998) Chandelier cell axons are immunoreactive for GAT-1 in the human neocortex. NeuroReport 9:467-470
31. DeFelipe J, Hendry SHC, Jones EG (1989) Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc Natl Acad Sci USA 86:2093-2097
32. Elvevåg B, Goldberg TE (2000) Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14:1-21
33. Erickson SL, Lewis DA (2002) Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex. J Comp Neurol 448:186-202
34. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 359:154-194
35. A receptor subunits revealed by antigen-retrieval immunohistochemistry. J Comp Neurol 390:194-210
36. Gabbott PLA, Bacon SJ (1996) Local circuit neurons in the medial prefrontal cortex (areas 24a,b,c, 25 and 32) in the monkey: II. Quantitative areal and laminar distributions. J Comp Neurol 364:609-636
37. Gabbott PLA, Dickie BGM, Vaid RR, Headlam AJM, Bacon SJ (1997) Local-circuit neurones in the medial prefrontal cortex (areas 25, 32 and 24b) in the rat: Morphology and quantitative distribution. J Comp Neurol 377:465-499
38. Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR (1997) Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 54:159-165
39. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-330
40. Green MF (1998) Schizophrenia from a neurocognitive perspective: probing the impenetrable darkness. Allyn and Bacon, Boston, Mass.
41. 67) expression in schizophrenia and bipolar disorder. Arch Gen Psychiatry 57:1061-1069
42. Gulledge AT, Stuart GJ (2003) Excitatory actions of GABA in the cortex. Neuron 37:299-309
43. Gur RC, Gur RE (1995) Hypofrontality in schizophrenia: RIP. Lancet 345:1383-1384
44. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98:4746-4751
45. Harvey PD, Howanitz E, Parrella M, White L, Davidson M, Mohs RC, Hoblyn J, Davis KL (1998) Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry 155:1080-1086
46. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA (2003) Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23:6315-6326
47. D28k- immunoreactive neurons in layer V of rat frontal cortex. J Neurophysiol 70:387-396
48. Keefe RSE, Roitman SEL, Harvey PD, Blum CS, DuPre RL, Prieto DM, Davidson D, Davis KL (1995) A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia. Schizophr Res 17:25-33
49. Klausberger T, Magill PJ, Marton LF, Roberts JDB, Cobden PM, Buzsaki G, Somogyi P (2003) Brain-state- and cell-type specific firing of hippocampal interneurons in vivo. Nature 421:844-848
50. Krimer LS, Goldman-Rakic PS (2001) Prefrontal microcircuits: membrane properties and excitatory input of local, medium, and wide arbor neurons. J Neurosci 21:3788-3796
51. Letinic K, Zoncu R, Rakic P (2002) Origin of GABAergic neurons in the human neocortex. Nature 417:645-649
52. Lewis DA, Lund JS (1990) Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor and parvalbumin immunoreactive populations. J Comp Neurol 293:599-615
53. Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo T-U (1999) Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry 46:616-626
54. A receptor subunits in the human brain. J Histochem Cytochem 46:1129-1139
55. Löw K, Crestani F, Keist R, Benke D, Brünig I, Benson JA, Fritschy J-M, Rülicke T, Bluethmann H, Mönler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131-134
56. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, Saper CB, Warach S (1999) Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 45:1128-1137
57. 1 subtype. Nat Neurosci 3:587-592
58. Melchitzky DS, Lewis DA (2003) Pyramidal neuron local axon terminlas in monkey prefrontal cortex: Differential targeting of subclasses of GABA neurons. Cereb Cortex 13:452-460
59. Melchitzky DS, Sesack SR, Lewis DA (1999) Parvalbumin-immunoreactive axon terminals in macaque monkey and human prefrontal cortex: Laminar, regional and target specificity of type I and type II synapses. J Comp Neurol 408:11-22
60. Melchitzky DS, Gonzalez-Burgos G, Barrionuevo G, Lewis DA (2001) Synaptic targets of the intrinsic axon collaterals of supragranular pyramidal neurons in monkey prefrontal cortex. J Comp Neurol 430:209-221
61. Mimics K, Middleton FA, Marquez A, Lewis DA, Levitt P (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67
62. Mirsky AF (1969) Neuropsychological bases of schizophrenia. Annu Rev Psychol 20:321-348
63. Neuchterlein KH, Dawson ME (1984) Information processing and attentional functioning in the developmental course of schizophrenia disorders. Schizophr Bull 10:160-203
64. Nusser Z, Sieghart W, Benke D, Fritschy J-M, Somogyi P (1996) Differential synaptic localization of two major γ-aminobutyric acid type A receptor a subunits on hippocampal pyramidal cells. Proc Natl Acad Sci USA 93:11939-11944
65. Park S, Holzman PS (1992) Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49:975-982
66. Peters A (1984) Chandelier cells. In: Jones EG, Peters A (eds) Cerebral cortex, vol 1. Plenum Press, New York, pp 361-380
67. Pierri JN, Chaudry AS, Woo T-U, Lewis DA (1999) Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry 156:1709-1719
68. Posner MI, Di Girolamo GJ (1998) The attentive brain. MIT Press, Cambridge
69. Pouille F, Scanziani M (2001) Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition. Science 293:1159-1163
70. Rao SG, Williams GV, Goldman-Rakic PS (1999) Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: evidence for microcolumnar organization in PFC. J Neurophysiol 81:1903-1916
71. A blockade of prefrontal cortical neurons engaged by working memory. J Neurosci 20:485-494
72. A receptor subtypes. Nature 401:796-800
73. Shallice T (1988) From neuropsychology to mental structure. Cambridge University Press, Cambridge
74. Shu Y, Hasenstaub A, McCormick DA (2003) Turning on and off recurrent balanced cortical activity. Nature 423:288-293
75. Spencer KM, Nestor PG, Salisbury DF, Shenton ME, McCarley RW (2003) Abnormal neural synchrony in schizophrenia. J Neurosci 23:7407-7411
76. Tallon-Baudry C, Bertrand O, Peronnet F, Pernier J (1998) Induced gamma-band activity during the delay of a visual short-term memory task in humans. J Neurosci 18:4244-4254
77. Taylor SF (1996) Cerebral blood flow activation and functional lesions in schizophrenia. Schizophr Res 19:129-140
78. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG, Freed WJ (2002) Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 58:11-20
79. Volk DW, Lewis DA (2002) Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav 77:501-505
80. 67 mRNA expression in a subset of prefrontal cortical GABA neurons in subjects with schizophrenia. Arch Gen Psychiatry 57:237-245
81. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA (2001) GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 158:256-265
82. Volk DW, Pierri JN, Fritschy J-M, Auh S, Sampson AR, Lewis DA (2002) Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 12:1063-1070
83. Weinberger DR, Gallhofer B (1997) Cognitive dysfunction in schizophrenia. Int Clin Psychopharmacol 128:29-36
84. Weinberger DR, Berman KF, Zec RF (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43:114-124
85. Weinberger DR, Berman KF, Illowsky BP (1988) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 45:609-615
86. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE (2001) Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50:825-844
87. Wilson FA, O Scalaidhe SP, Goldman-Rakic PS (1994) Functional synergism between putative gamma-aminobutyrate-containing neurons and pyramidal neurons in prefrontal cortex. Proc Natl Acad Sci USA 91:4009-4013
88. Wolkowitz OM, Pickar D (1991) Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. Am J Psychiatry 148:714-726
89. Woo T-U, Miller JL, Lewis DA (1997) Parvalbumin-containing cortical neurons in schizophrenia. Am J Psychiatry 154:1013-1015
90. Woo T-U, Whitehead RE, Melchitzky DS, Lewis DA (1998) A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 95:5341-5346
91. Xu Q, de la Cruz E, Anderson SA (2003) Cortical interneuron fate determination: diverse sources for distinct subtypes? Cereb Cortex 13:670-676